tiprankstipranks
Trending News
More News >
Xilio Therapeutics (XLO)
NASDAQ:XLO
US Market
Advertisement

Xilio Therapeutics (XLO) Technical Analysis

Compare
200 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Xilio Therapeutics’s (XLO) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Xilio Therapeutics is a Sell.
Xilio Therapeutics’s (XLO) 20-Day exponential moving average is 0.75, while Xilio Therapeutics’s (XLO) share price is $0.76, making it a Buy.
Xilio Therapeutics’s (XLO) 50-Day exponential moving average is 0.73, while Xilio Therapeutics’s (XLO) share price is $0.76, making it a Buy.

Xilio Therapeutics (XLO) Pivot Points

Sep 28, 2025, 03:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.73
0.74
0.75
0.76
0.77
0.78
0.79
Fibonacci
0.74
0.75
0.75
0.76
0.77
0.77
0.78
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Xilio Therapeutics (XLO) Moving Averages

Sep 28, 2025, 03:04 AM
Period
Simple
Exponential
MA5
0.77Buy
0.77Buy
MA10
0.77Buy
0.76Buy
MA20
0.74Buy
0.75Buy
MA50
0.71Buy
0.73Buy
MA100
0.73Buy
0.74Buy
MA200
0.80Sell
0.81Sell
Xilio Therapeutics’s (XLO) 10-Day exponential moving average is 0.76, while Xilio Therapeutics’s (XLO) share price is $0.76, making it a Buy.
Xilio Therapeutics’s (XLO) 100-Day exponential moving average is 0.74, while Xilio Therapeutics’s (XLO) share price is $0.76, making it a Buy.
Xilio Therapeutics’s (XLO) stock price is $0.76 and Xilio Therapeutics’s (XLO) 50-day simple moving average is 0.71, creating a Buy signal.
Xilio Therapeutics’s (XLO) stock price is $0.76 and Xilio Therapeutics’s (XLO) 100-day simple moving average is 0.73, creating a Buy signal.
Xilio Therapeutics’s (XLO) stock price is $0.76 and Xilio Therapeutics’s (XLO) 200-day simple moving average is 0.80, creating a Sell signal.

Xilio Therapeutics (XLO) Technical Indicators

Sep 28, 2025, 03:04 AM
Name
Value
Implied Action
RSI (14)
66.87
Neutral
STOCH (9,6)
67.66
Neutral
STOCHRSI (14)
70.53
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
39.44
Neutral
Williams %R
-21.74
Buy
CCI (14)
131.36
Sell
ATR (14)
0.04
-
Ultimate Oscillator
63.75
Neutral
ROC
14.29
Buy
Xilio Therapeutics’s (XLO) Relative Strength Index (RSI) is 66.87, creating a Neutral signal.
Xilio Therapeutics’s (XLO) Trend Strength Indicator (ADX) is 39.44, creating a Neutral signal.
Xilio Therapeutics’s (XLO) Commodity Channel Index (CCI) is 131.36, creating a Sell signal.
Xilio Therapeutics’s (XLO) Price Rate of Change (ROC) is 14.29, creating a Buy signal.

FAQ

Is XLO a Buy, Hold, or Sell?
Based on XLO’s technical indicators, XLO is a Buy.
    What is XLO’s RSI (14)?
    XLO’s RSI (14) is 66.87, which suggests XLO is a Neutral.
      What is XLO’s MACD?
      XLO’s MACD is 0.02, which suggests XLO is a Sell.
        What is XLO’s 5-day moving average?
        XLO’s 5-day moving average is 0.77, which suggests XLO is a Buy.
          What is XLO’s 20-day moving average?
          XLO 20-day moving average is 0.74, which suggests XLO is a Buy.
            What is XLO’s 50-day moving average?
            XLO’s 50-day moving average is 0.71, which suggests XLO is a Buy.
              What is XLO’s 200-day moving average?
              XLO’s 200-day moving average is 0.80, which suggests XLO is a Sell.
                What is XLO’s Williams % R (14)?
                XLO’s Williams % R (14) is -21.74, which suggests XLO is a Buy.
                  What is XLO’s CCI (14)?
                  XLO’s CCI (14) is 131.36, which suggests XLO is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis